Tomás G. Lyons

571 total citations
18 papers, 442 citations indexed

About

Tomás G. Lyons is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tomás G. Lyons has authored 18 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Tomás G. Lyons's work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Tomás G. Lyons is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Tomás G. Lyons collaborates with scholars based in United States and Ireland. Tomás G. Lyons's co-authors include Geoffrey Y. Ku, Tiffany A. Traina, Mark E. Robson, Grainne M. O’Kane, Catherine M. Kelly, Maura N. Dickler, Gabrielle Colleran, David Fitzpatrick, Derek G. Power and Sandra Murphy and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Tomás G. Lyons

18 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás G. Lyons United States 10 219 219 106 96 60 18 442
Jelena Urosevic Spain 8 221 1.0× 227 1.0× 72 0.7× 111 1.2× 57 0.9× 10 462
Sara G. Manore United States 9 313 1.4× 256 1.2× 82 0.8× 126 1.3× 77 1.3× 13 579
Yanqiu Song China 13 268 1.2× 125 0.6× 61 0.6× 104 1.1× 49 0.8× 34 445
Guoxian Long China 15 289 1.3× 291 1.3× 108 1.0× 217 2.3× 45 0.8× 35 661
Songtao Lai China 11 314 1.4× 251 1.1× 90 0.8× 168 1.8× 105 1.8× 21 645
Iwona Gisterek Poland 11 144 0.7× 183 0.8× 62 0.6× 112 1.2× 86 1.4× 51 427
Un-Jung Yun South Korea 6 289 1.3× 202 0.9× 115 1.1× 170 1.8× 42 0.7× 10 511
Ilenia Segatto Italy 14 290 1.3× 251 1.1× 99 0.9× 198 2.1× 39 0.7× 23 536

Countries citing papers authored by Tomás G. Lyons

Since Specialization
Citations

This map shows the geographic impact of Tomás G. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás G. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás G. Lyons more than expected).

Fields of papers citing papers by Tomás G. Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás G. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás G. Lyons. The network helps show where Tomás G. Lyons may publish in the future.

Co-authorship network of co-authors of Tomás G. Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás G. Lyons. A scholar is included among the top collaborators of Tomás G. Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás G. Lyons. Tomás G. Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Diana G., Dulce M. Barrios, Victoria Blinder, et al.. (2020). Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer. Breast Cancer Research and Treatment. 183(1). 227–237. 30 indexed citations
2.
Barrios, Dulce M., Diana G. Wang, Victoria Blinder, et al.. (2020). Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.. Journal of Clinical Oncology. 38(15_suppl). 1063–1063. 2 indexed citations
3.
Lyons, Tomás G. & Tiffany A. Traina. (2019). Emerging Novel Therapeutics in Triple-Negative Breast Cancer. Advances in experimental medicine and biology. 1152. 377–399. 17 indexed citations
4.
Lyons, Tomás G.. (2019). Targeted Therapies for Triple-Negative Breast Cancer. Current Treatment Options in Oncology. 20(11). 82–82. 242 indexed citations
5.
Lyons, Tomás G. & Mark E. Robson. (2018). Resurrection of PARP Inhibitors in Breast Cancer. Journal of the National Comprehensive Cancer Network. 16(9). 1150–1156. 17 indexed citations
6.
Lyons, Tomás G., et al.. (2018). Checkpoint Inhibitors in the Treatment of Breast Cancer. Current Oncology Reports. 20(7). 51–51. 10 indexed citations
7.
Lyons, Tomás G., Ayca Gucalp, Sujata Patil, et al.. (2018). Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 531–531. 2 indexed citations
8.
Lyons, Tomás G. & Geoffrey Y. Ku. (2017). Systemic therapy for esophagogastric cancer: immune checkpoint inhibition. Chinese Clinical Oncology. 6(5). 53–53. 5 indexed citations
9.
Lyons, Tomás G. & Geoffrey Y. Ku. (2017). Systemic therapy for esophagogastric cancer: targeted therapies. Chinese Clinical Oncology. 6(5). 48–48. 30 indexed citations
10.
Lyons, Tomás G., et al.. (2017). BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods. Journal of Clinical Pathology. 70(11). 935–940. 17 indexed citations
11.
Lyons, Tomás G. & Tiffany A. Traina. (2017). Androgen Receptor-Targeted Therapy for Breast Cancer. Current Breast Cancer Reports. 9(4). 242–250. 1 indexed citations
12.
Murtagh, Gillian, Tomás G. Lyons, Eoin O’Connell, et al.. (2016). Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up. Breast Cancer Research and Treatment. 156(3). 501–506. 22 indexed citations
13.
Murtagh, Gillian, et al.. (2015). 1939 Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant Doxorubicin: 10-Year follow-up. European Journal of Cancer. 51. S311–S312. 2 indexed citations
14.
Lyons, Tomás G., et al.. (2014). Vismodegib in the treatment of advanced BCC.. PubMed. 107(7). 215–6. 4 indexed citations
15.
O’Kane, Grainne M., Tomás G. Lyons, Gabrielle Colleran, et al.. (2014). Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma. Oncology Research and Treatment. 37(12). 757–760. 27 indexed citations
16.
Lyons, Tomás G., Grainne M. O’Kane, & Catherine M. Kelly. (2014). Efficacy and safety of vismodegib: a new therapeutic agent in the treatment of basal cell carcinoma. Expert Opinion on Drug Safety. 13(8). 1125–1132. 11 indexed citations
17.
Lyons, Tomás G., et al.. (2013). Gastrointestinal cancer risk in Irish hereditary breast ovarian cancer families.. Journal of Clinical Oncology. 31(15_suppl). e12565–e12565. 1 indexed citations
18.
Zuradelli, Monica, Fergal C. Kelleher, Francesco Sclafani, et al.. (2011). 5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT). European Journal of Cancer. 47. S329–S330. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jelena Urosevic Breakdown of academic impact, for papers by Sara G. Manore Breakdown of academic impact, for papers by Yanqiu Song Breakdown of academic impact, for papers by Guoxian Long Breakdown of academic impact, for papers by Songtao Lai Breakdown of academic impact, for papers by Iwona Gisterek Breakdown of academic impact, for papers by Un-Jung Yun Breakdown of academic impact, for papers by Ilenia Segatto
Rankless by CCL
2026